These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 453214)
1. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease. Dasta J; Mirtallo JM; Altman M Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214 [No Abstract] [Full Text] [Related]
2. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease. Fontana G; Cresci F; Lo Sapio P; Panuccio P Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008 [TBL] [Abstract][Full Text] [Related]
3. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice. Arbab OA; Wiggins J; Ayres JG; Stableforth DE Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120 [TBL] [Abstract][Full Text] [Related]
4. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease]. Harder S; Staib AH; Stauder J Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931 [No Abstract] [Full Text] [Related]
5. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form]. Kaik G Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156 [TBL] [Abstract][Full Text] [Related]
6. Effect of theophylline in chronic obstructive lung disease. Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541 [TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations. Giosue S; Bernocchi D; Parola D; Munno R; Mancini P J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318 [TBL] [Abstract][Full Text] [Related]
8. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels. Steinijans VW; Zech K; Fischer R Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100 [TBL] [Abstract][Full Text] [Related]
9. Theophylline levels in patients receiving a controlled-release aminophylline preparation (Phyllocontin Continus tablets). Friend JA J Int Med Res; 1979; 7 Suppl 1():67-9. PubMed ID: 437310 [TBL] [Abstract][Full Text] [Related]
10. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations]. Wiesner B; Sehrt I; Iwainsky H Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957 [TBL] [Abstract][Full Text] [Related]
11. Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease. Silins RA; Butcher MA; Marlin GE Br J Clin Pharmacol; 1984 Oct; 18(4):645-7. PubMed ID: 6487509 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline. Gupta S; Raina RK; Samotra K; Gupta KL Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015 [TBL] [Abstract][Full Text] [Related]
13. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline. Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630 [TBL] [Abstract][Full Text] [Related]
14. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction. Freitag A Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924 [TBL] [Abstract][Full Text] [Related]
16. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion. Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483 [TBL] [Abstract][Full Text] [Related]
17. [Prescription of Theostat 300 as a single evening dose]. Germouty J; Bida C; Moreau L Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266 [TBL] [Abstract][Full Text] [Related]
18. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations]. Ranke C; Schmidt G; Oellerich M; Sybrecht GW Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564 [No Abstract] [Full Text] [Related]
19. Clinical results obtained from a new controlled release theophylline preparation. Nolte D Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017 [No Abstract] [Full Text] [Related]
20. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation. Dal Negro R; Turco P; Pomari C; Monici-Preti P Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]